GENEVA, July 18 -- BIOCRYST PHARMACEUTICALS, INC. filed a patent application (US2026/010780) for “USE OF AVORALSTAT IN THE TREATMENT OF DIABETIC MACULAR EDEMA AND RELATED OCULAR DISEASES”. With publication no. WO/2026/151989, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/44
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....